Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Principled versus statistical thinking in diagnosis and treatment of stroke.

Current treatment options in cardiovascular medicine·2010
Same author

Artificial adaptive systems and fuzzy measures for translation of clinical trial results to the bedside.

Current treatment options in cardiovascular medicine·2009
Same author

Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke.

Cerebrovascular diseases (Basel, Switzerland)·2009
Same author

Measurable prediction for the single patient and the results of large double blind controlled randomized trials.

PloS one·2008
Same author

Platelet aggregation and recruitment with aspirin-clopidogrel therapy.

Cerebrovascular diseases (Basel, Switzerland)·2008
Same author

Factors influencing warfarin dose requirements in African-Americans.

Pharmacogenomics·2007

Related Experiment Video

Updated: May 22, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Blood glucose and stroke.

Cathy M Helgason1

  • 1University of Illinois College of Medicine at Chicago, Chicago, IL, 60612, USA, helgason@uic.edu.

Current Treatment Options in Cardiovascular Medicine
|May 9, 2012
PubMed
Summary

Managing blood glucose in stroke patients is complex, requiring integration of clinical trial data with emerging research. Prudent management aims to prevent severe hyperglycemia and hypoglycemia for better outcomes.

Area of Science:

  • Neurology
  • Endocrinology
  • Clinical Medicine

Background:

  • Current stroke treatment guidelines for abnormal blood glucose are evidence-based.
  • New research in neuroimaging, tissue, and animal studies reveals additional factors influencing diabetes and stroke.
  • Physicians must integrate these findings with large clinical trial data for comprehensive patient care.

Purpose of the Study:

  • To emphasize the need for a holistic approach to managing blood glucose in stroke patients.
  • To highlight the importance of considering diverse evidence beyond large randomized trials.

Main Methods:

  • Review of current evidence-based guidelines for stroke and glucose management.
  • Synthesis of findings from neuroimaging, tissue studies, animal models, case series, and reports.

More Related Videos

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Related Experiment Videos

Last Updated: May 22, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

  • Integration of diverse data to inform clinical decision-making.

    • Main Results:

    • Hyperglycemia is associated with worse outcomes and increased mortality in acute stroke.
    • Avoiding both hypoglycemia and severe hyperglycemia is crucial for patient safety and recovery.
    • These principles apply to both ischemic and hemorrhagic stroke.

    Conclusions:

    • Physicians should consider all available evidence, not just large trials, to forecast treatment outcomes.
    • Careful glucose management, avoiding extremes, is essential for improving stroke patient prognosis.
    • Aggressive glucose-lowering strategies require caution to prevent hypoglycemia.